These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7499820)
21. Identification and characteristics of imipenem-resistant Acinetobacter baumannii in surgical wards in a Chinese university hospital. Wang D; Ma L; Wu Z; Li M; Li X; Zhang W; Chen K Infect Dis (Lond); 2015 Mar; 47(3):182-6. PubMed ID: 25622942 [TBL] [Abstract][Full Text] [Related]
22. Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units. Ho CM; Ho MW; Chi CY; Lin CD; Lin CW; Tseng SP; Teng LJ; Chang HY; Chang HL; Chang YF; Lin HH; Tien N; Lu JJ; Lai CH Surg Infect (Larchmt); 2013 Feb; 14(1):43-8. PubMed ID: 23425282 [TBL] [Abstract][Full Text] [Related]
23. Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit. Crowe M; Towner KJ; Humphreys H J Med Microbiol; 1995 Jul; 43(1):55-62. PubMed ID: 7608957 [TBL] [Abstract][Full Text] [Related]
24. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. Struelens MJ; Carlier E; Maes N; Serruys E; Quint WG; van Belkum A J Hosp Infect; 1993 Sep; 25(1):15-32. PubMed ID: 7901273 [TBL] [Abstract][Full Text] [Related]
26. A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China. Ye D; Shan J; Huang Y; Li J; Li C; Liu X; He W; Li Y; Mao P BMC Infect Dis; 2015 Apr; 15():179. PubMed ID: 25886493 [TBL] [Abstract][Full Text] [Related]
27. Phenotypic and genetic relationship of Acinetobacter Baumannii isolates. Trajkovska-Dokic E; Kotevska V; Kaftandzieva A; Jankoska G; Mircevska G; Petrovska M; Panovski N Prilozi; 2011; 32(2):157-68. PubMed ID: 22286620 [TBL] [Abstract][Full Text] [Related]
28. Emergence of multidrug-resistant isolates of Acinetobacter baumannii. Okpara AU; Maswoswe JJ Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578 [TBL] [Abstract][Full Text] [Related]
30. Genetic relatedness of clinical and environmental Acinetobacter baumanii isolates from an intensive care unit outbreak. Senok A; Garaween G; Raji A; Khubnani H; Kim Sing G; Shibl A J Infect Dev Ctries; 2015 Jul; 9(6):665-9. PubMed ID: 26142679 [TBL] [Abstract][Full Text] [Related]
31. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. Al-Sweih NA; Al-Hubail MA; Rotimi VO J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488 [TBL] [Abstract][Full Text] [Related]
32. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178 [TBL] [Abstract][Full Text] [Related]
33. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel. Simhon A; Rahav G; Shazberg G; Block C; Bercovier H; Shapiro M J Clin Microbiol; 2001 Jan; 39(1):389-91. PubMed ID: 11136809 [TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii. Douraghi M; Ghalavand Z; Nateghi Rostami M; Zeraati H; Aliramezani A; Rahbar M; Mohammadzadeh M; Ghourchian S; Boroumand MA; Abdollahi A J Appl Microbiol; 2016 Aug; 121(2):401-7. PubMed ID: 27171885 [TBL] [Abstract][Full Text] [Related]
35. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. Héritier C; Dubouix A; Poirel L; Marty N; Nordmann P J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718 [TBL] [Abstract][Full Text] [Related]
36. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA. Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090 [TBL] [Abstract][Full Text] [Related]
37. Epidemiological characterization of Acinetobacter baumannii bloodstream isolates from a Chinese Burn Institute: A three-year study. Huang G; Yin S; Xiang L; Gong Y; Sun K; Luo X; Zhang C; Yang Z; Deng L; Jiang B; Jin S; Chen J; Peng Y Burns; 2016 Nov; 42(7):1542-1547. PubMed ID: 27614427 [TBL] [Abstract][Full Text] [Related]
38. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857 [TBL] [Abstract][Full Text] [Related]
39. Identification of Genomic Species of Acinetobacter Isolated from Burns of ICU Patients. Shaykh Baygloo N; Bouzari M; Rahimi F; Abedini F; Yadegari S; Soroushnia M; Beigi F Arch Iran Med; 2015 Oct; 18(10):638-42. PubMed ID: 26443247 [TBL] [Abstract][Full Text] [Related]
40. Fortuitous diagnosis of NDM-1-producing Acinetobacter pittii carriage in a patient from France with no recent history of travel. Pailhoriès H; Hadjadj L; Mahieu R; Crochette N; Rolain JM; Kempf M J Antimicrob Chemother; 2017 Mar; 72(3):942-944. PubMed ID: 27999060 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]